Literature DB >> 20530515

Tumor-initiating cells: an influential paradigm for xenograft research.

C David James.   

Abstract

Mesh：

Year:  2010        PMID： 20530515      PMCID： PMC2940644          DOI： 10.1093/neuonc/noq053

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  5 in total

1.  DISTRIBUTION OF FLUORESCENT TRACERS IN HETEROLOGOUSLY TRANSPLANTED INTRACEREBRAL TUMORS.

Authors:  M R KRIGMAN; E E MANUELIDIS
Journal:  Cancer Res       Date:  1964-11       Impact factor: 12.701

2.  Heterotransplantation of human glioblastoma multiforme and meningioma to nude mice.

Authors:  M W Rana; H Pinkerton; H Thornton; D Nagy
Journal:  Proc Soc Exp Biol Med       Date:  1977-05

3.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

4.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

5.  A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo.

Authors:  Litian Yu; Patricia A Baxter; Horatiu Voicu; Sivashankarappa Gurusiddappa; Yijue Zhao; Adekunle Adesina; Tsz-Kwong Man; Qin Shu; Yu-Jing Zhang; Xiu-Mei Zhao; Jack M Su; Lazlo Perlaky; Robert Dauser; Murali Chintagumpala; Ching C Lau; Susan M Blaney; Pulivarthi H Rao; Hon-Chiu Eastwood Leung; Xiao-Nan Li
Journal:  Neuro Oncol       Date:  2010-02-08       Impact factor: 12.300
  5 in total
  1 in total

Review 1.  Current status and evolution of preclinical drug development models of epithelial ovarian cancer.

Authors:  Panagiotis A Konstantinopoulos; Ursula A Matulonis
Journal:  Front Oncol       Date:  2013-12-11       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.